AU2001252917A1 - 7 human ovarian and ovarian cancer associated proteins - Google Patents

7 human ovarian and ovarian cancer associated proteins

Info

Publication number
AU2001252917A1
AU2001252917A1 AU2001252917A AU5291701A AU2001252917A1 AU 2001252917 A1 AU2001252917 A1 AU 2001252917A1 AU 2001252917 A AU2001252917 A AU 2001252917A AU 5291701 A AU5291701 A AU 5291701A AU 2001252917 A1 AU2001252917 A1 AU 2001252917A1
Authority
AU
Australia
Prior art keywords
ovarian
associated proteins
cancer associated
human
ovarian cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252917A
Inventor
Charles E. Birse
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001252917A1 publication Critical patent/AU2001252917A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57449Specifically defined cancers of ovaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001252917A 2000-03-17 2001-03-16 7 human ovarian and ovarian cancer associated proteins Abandoned AU2001252917A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19007600P 2000-03-17 2000-03-17
US60190076 2000-03-17
US22700900P 2000-08-23 2000-08-23
US60227009 2000-08-23
PCT/US2001/008585 WO2001070804A1 (en) 2000-03-17 2001-03-16 7 human ovarian and ovarian cancer associated proteins

Publications (1)

Publication Number Publication Date
AU2001252917A1 true AU2001252917A1 (en) 2001-10-03

Family

ID=26885755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252917A Abandoned AU2001252917A1 (en) 2000-03-17 2001-03-16 7 human ovarian and ovarian cancer associated proteins

Country Status (5)

Country Link
EP (1) EP1268541A1 (en)
JP (1) JP2003527851A (en)
AU (1) AU2001252917A1 (en)
CA (1) CA2400638A1 (en)
WO (1) WO2001070804A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044813A1 (en) * 2001-03-30 2003-03-06 Old Lloyd J. Cancer-testis antigens
AU2002254615A1 (en) * 2001-04-17 2002-10-28 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
US7309760B2 (en) 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
RS20050300A (en) 2002-10-16 2007-08-03 Euro-Celtique S.A., Antibodies that bind cell-associated ca 125/0772p and methods of use thereof
NZ570201A (en) * 2003-02-11 2011-03-31 Shire Human Genetic Therapies Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
EP2056110A1 (en) * 2007-10-31 2009-05-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
US20160145589A1 (en) 2011-06-24 2016-05-26 Green Cross Corporation Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
KR101380740B1 (en) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 Purification of iduronate-2-sulfatase
US9150841B2 (en) 2012-06-29 2015-10-06 Shire Human Genetic Therapies, Inc. Cells for producing recombinant iduronate-2-sulfatase
BR112017002888A2 (en) 2014-08-12 2017-12-05 Nextgen Jane Inc system and method for health monitoring in body fluid collected
EP3442706A4 (en) 2016-04-13 2020-02-19 NextGen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457038A (en) * 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor

Also Published As

Publication number Publication date
JP2003527851A (en) 2003-09-24
WO2001070804A1 (en) 2001-09-27
EP1268541A1 (en) 2003-01-02
CA2400638A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
AUPR814401A0 (en) Human 3 relaxin
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU1608201A (en) Human zven proteins
AU2001252917A1 (en) 7 human ovarian and ovarian cancer associated proteins
AU2001286721A1 (en) Human interleukin-four induced protein
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU7089800A (en) 29 human cancer associated proteins
GB0200204D0 (en) Cosmetic and related preparations
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001241875A1 (en) Human dynamin 40322
AU2136401A (en) P450rai-2 and related proteins
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU3411999A (en) Novel rnase-like protein and its use
AU4992099A (en) Human presenilin-associated protein
AU2593199A (en) Human smn-like protein
AU4438599A (en) Human arf-related proteins
AU2001231141A1 (en) Novel human septin and uses thereof
AU2002360333A1 (en) Human angiomotin-like protein 1
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof
AU2002343516A1 (en) Structural and cytoskeleton-associated proteins
AU2002320621A1 (en) Structural and cytoskeleton-associated proteins
AU2001255763A1 (en) 13295 novel protein kinase molecules and uses therefor
AU2001279046A1 (en) 18431 and 32374, human protein kinase family members and uses therefor